Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Tidswell

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Critical Care Medicine|August 8, 2009
Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsisMark Tidswell, William Tillis, Steven P Larosa, et al.
Critical Care Medicine|January 16, 2016
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot StudyMichael W Donnino, Lars W Andersen, Maureen Chase, et al.
Critical Care Medicine|January 20, 2015
Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome*Colin K Grissom, Eliotte L Hirshberg, Justin B Dickerson, et al.
Critical Care Medicine|June 4, 2008
A replicable method for blood glucose control in critically Ill patientsAlan H Morris, James Orme, Jonathon D Truwit, et al.
American Journal of Respiratory and Critical Care Medicine|June 21, 2008
Randomized clinical trial of activated protein C for the treatment of acute lung injuryKathleen D Liu, Joseph Levitt, Hanjing Zhuo, et al.
Critical Care Medicine|May 25, 2017
Nonlinear Imputation of PaO2/FIO2 From SpO2/FIO2 Among Mechanically Ventilated Patients in the ICU: A Prospective, Observational StudySamuel M Brown, Abhijit Duggal, Peter C Hou, et al.
Critical Care (London, England)|September 8, 2017
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndromeAkram Khan, Cody Benthin, Brian Zeno, et al.
Critical Care (London, England)|November 8, 2023
Bayesian methods: a potential path forward for sepsis trialsGeorge Tomlinson, Ali Al-Khafaji, Steven A Conrad, et al.
Critical Care (London, England)|January 4, 2024
Correction to: Bayesian methods: a potential path forward for sepsis trialsGeorge Tomlinson, Ali Al-Khafaji, Steven A Conrad, et al.
Intensive Care Medicine|October 3, 2019
Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumabRichard S Hotchkiss, Elizabeth Colston, Sachin Yende, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Critical Care Medicine|August 8, 2009
Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsisMark Tidswell, William Tillis, Steven P Larosa, et al.
Critical Care Medicine|January 16, 2016
Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot StudyMichael W Donnino, Lars W Andersen, Maureen Chase, et al.
Critical Care Medicine|January 20, 2015
Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome*Colin K Grissom, Eliotte L Hirshberg, Justin B Dickerson, et al.
Critical Care Medicine|June 4, 2008
A replicable method for blood glucose control in critically Ill patientsAlan H Morris, James Orme, Jonathon D Truwit, et al.
American Journal of Respiratory and Critical Care Medicine|June 21, 2008
Randomized clinical trial of activated protein C for the treatment of acute lung injuryKathleen D Liu, Joseph Levitt, Hanjing Zhuo, et al.
Critical Care Medicine|May 25, 2017
Nonlinear Imputation of PaO2/FIO2 From SpO2/FIO2 Among Mechanically Ventilated Patients in the ICU: A Prospective, Observational StudySamuel M Brown, Abhijit Duggal, Peter C Hou, et al.
Critical Care (London, England)|September 8, 2017
A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndromeAkram Khan, Cody Benthin, Brian Zeno, et al.
Critical Care (London, England)|November 8, 2023
Bayesian methods: a potential path forward for sepsis trialsGeorge Tomlinson, Ali Al-Khafaji, Steven A Conrad, et al.
Critical Care (London, England)|January 4, 2024
Correction to: Bayesian methods: a potential path forward for sepsis trialsGeorge Tomlinson, Ali Al-Khafaji, Steven A Conrad, et al.
Intensive Care Medicine|October 3, 2019
Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumabRichard S Hotchkiss, Elizabeth Colston, Sachin Yende, et al.
Pageof 3